secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2026-06-17T20:05:37+00:00
Accession:  0001104659-26-075127
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron shareholders elect Class II directors, approve auditor and advisory compensation at annual meeting
--------------------------------------------------------------------------------

- All five Class II director nominees elected: Goldstein, Poon, Schenkein, Thompson, Zoghbi.
- Ratification of PwC as independent auditor for FY 2026: 102.5M for, 6.4M against, 68.8K abstain.
- Advisory vote on executive compensation approved: 96.5M for, 6.9M against, 105.5K abstain, 5.5M broker non-votes.
- Meeting held June 12, 2026; results reported June 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465926075127/0001104659-26-075127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465926075127/tm2618117d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer